Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Hypermelanotic macule, Alopecia, Squamous cell carcinoma, and Alopecia of scalp and others; and common findings: Hypomelanotic macule, Freckling, Premature loss of teeth, and Dry skin and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 7 | Alopecia, Alopecia of scalp, Dry skin |
SASH1 function has not been fully characterized.
Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome is associated with mutations in the SASH1 gene on chromosome 6.
Genetic testing for SASH1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 5 always present features, 8 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome.
28 publications have been identified in PubMed for pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (36%), and Other (7%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 14 | 50% |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 5:35 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Eyes
1 |
Visible small blood vessels in the eye (conjunctival telangiectasia) |
Research summaries |
10 |
36% |
Other research | 2 | 7% |
Laboratory research | 2 | 7% |
Carrasco G (2026). [PMID: 42091340](https://pubmed.ncbi.nlm.nih.gov/42091340/). *J Dermatol Sci*. [Basic Science / Preclinical]
Bansal SP (2026). [PMID: 41478811](https://pubmed.ncbi.nlm.nih.gov/41478811/). *Int J Oral Maxillofac Surg*. [Review / Meta-Analysis]
Ismedon M (2026). [PMID: 41944204](https://pubmed.ncbi.nlm.nih.gov/41944204/). *Ocul Immunol Inflamm*. [Case Report / Case Series]
Nykaza I (2026). [PMID: 41621676](https://pubmed.ncbi.nlm.nih.gov/41621676/). *J Am Acad Dermatol*. [Review / Meta-Analysis]
Ortiz-Flores AE (2026). [PMID: 42236016](https://pubmed.ncbi.nlm.nih.gov/42236016/). *Vitam Horm*. [Review / Meta-Analysis]
Murakami F (2026). [PMID: 41583049](https://pubmed.ncbi.nlm.nih.gov/41583049/). *Case Rep Oncol*. [Case Report / Case Series]
Nykaza I (2026). [PMID: 41621675](https://pubmed.ncbi.nlm.nih.gov/41621675/). *J Am Acad Dermatol*. [Review / Meta-Analysis]
Ricardo JW (2025). [PMID: 40023404](https://pubmed.ncbi.nlm.nih.gov/40023404/). *J Am Acad Dermatol*. [Review / Meta-Analysis]
Rooker A (2025). [PMID: 40613043](https://pubmed.ncbi.nlm.nih.gov/40613043/). *JAAD Case Rep*. [Case Report / Case Series]
Chowdhury D (2025). [PMID: 39858032](https://pubmed.ncbi.nlm.nih.gov/39858032/). *Cancers (Basel)*. [Review / Meta-Analysis]